Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonodynamic Therapy with Hematoporphyrin for Brainstem DIPG
NCT06999148Phase 2Enrolling by invitation
- Start
- Oct 2024
- Primary completion
- May 2028
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of hemoporfin in diffuse intrinsic pontine glioma (DIPG). Started Oct 2024; status: enrolling by invitation.
02
Drugs
hemoporfin
03
Conditions
diffuse intrinsic pontine glioma (DIPG)
Beyond the preview
Go deeper on NCT06999148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06999148.